Author Zetterberg, Henrik
-
2012 | Journal Article
Development and assessment of sensitive immuno-PCR assays for the quantification of cerebrospinal fluid three- and four-repeat tau isoforms in tauopathies
Luk, C.; Compta, Y.; Magdalinou, N.; Jose Marti, M.; Hondhamuni, G.; Zetterberg, H. & Blennow, K. et al. (2012)
Journal of Neurochemistry, 123(3) pp. 396-405. DOI: https://doi.org/10.1111/j.1471-4159.2012.07911.x
Details DOI PMID PMC WoS
-
2012 | Journal Article
Pyroglutamate Amyloid beta (A beta) Aggravates Behavioral Deficits in Transgenic Amyloid Mouse Model for Alzheimer Disease
Wittnam, J. L.; Portelius, E.; Zetterberg, H.; Gustavsson, M. K.; Schilling, S.; Koch, B. & Demuth, H.-U. et al. (2012)
Journal of Biological Chemistry, 287(11) pp. 8154-8162. DOI: https://doi.org/10.1074/jbc.M111.308601
Details DOI PMID PMC WoS
-
2013 | Journal Article | Research Paper
Analysis of amino-terminal variants of amyloid-β peptides by capillary isoelectric focusing immunoassay
Haußmann, U.; Jahn, O. ; Linning, P.; Janßen, C.; Liepold, T.; Portelius, E. & Zetterberg, H. et al. (2013)
Analytical Chemistry, 85(17) pp. 8142-8149. DOI: https://doi.org/10.1021/ac401055y
Details DOI PMID PMC
-
2014 | Journal Article
Highly potent soluble amyloid-β seeds in human Alzheimer brain but not cerebrospinal fluid
Fritschi, S. K.; Langer, F.; Kaeser, S. A.; Maia, L. F.; Portelius, E.; Pinotsi, D. & Kaminski, C. F. et al. (2014)
Brain, 137(11) pp. 2909-2915. DOI: https://doi.org/10.1093/brain/awu255
Details DOI
-
2015 | Journal Article
Prevalence of Cerebral Amyloid Pathology in Persons Without Dementia
Jansen, W. J.; Ossenkoppele, R.; Knol, D. L.; Tijms, B. M.; Scheltens, P.; Verhey, F. R. J. & Visser, P. J. et al. (2015)
JAMA, 313(19) art. 1924. DOI: https://doi.org/10.1001/jama.2015.4668
Details DOI
-
2015 | Journal Article |
A practical guide to immunoassay method validation
Andreasson, U.; Perret-Liaudet, A.; van Waalwijk van Doorn, L. J. C.; Blennow, K.; Chiasserini, D.; Engelborghs, S. & Fladby, T. et al. (2015)
Frontiers in Neurology, 6 art. UNSP 179. DOI: https://doi.org/10.3389/fneur.2015.00179
Details DOI PMID PMC WoS
-
2015 | Journal Article
Validation of a quantitative cerebrospinal fluid alpha-synuclein assay in a European-wide interlaboratory study
Kruse, N.; Persson, S.; Alcolea, D.; Bahl, J. M. C.; Baldeiras, I.; Capello, E. & Chiasserini, D. et al. (2015)
Neurobiology of Aging, 36(9) pp. 2587-2596. DOI: https://doi.org/10.1016/j.neurobiolaging.2015.05.003
Details DOI PMID PMC WoS
-
2015 | Journal Article |
The central biobank and virtual biobank of BiOMarKaPD: a resource for studies on neurodegenerative diseases
Reijs, B. L. R.; Teunissen, C. E.; Goncharenko, N.; Betsou, F.; Blennow, K.; Baldeiras, I. & Brosseron, F. et al. (2015)
Frontiers in Neurology, 6 art. UNSP 216. DOI: https://doi.org/10.3389/fneur.2015.00216
Details DOI PMID PMC WoS
-
2016 | Journal Article
Comparison of Different Matrices as Potential Quality Control Samples for Neurochemical Dementia Diagnostics
Lelental, N.; Brandner, S.; Kofanova, O.; Blennow, K.; Zetterberg, H.; Andreasson, U. & Engelborghs, S. et al. (2016)
Journal of Alzheimer's Disease, 52(1) pp. 51-64. DOI: https://doi.org/10.3233/jad-150883
Details DOI
-
2016 | Journal Article
Multicenter immunoassay validation of cerebrospinal fluid neurofilament light: a biomarker for neurodegeneration
Miller, A.-M.; Rutkowska, A.; Bahl, J. M. C.; Herukka, S.-K.; Koel-Simmelink, M. J. A.; Kruse, N. & Mollenhauer, B. et al. (2016)
Bioanalysis, 8(21) pp. 2243-2254. DOI: https://doi.org/10.4155/bio-2016-0114
Details DOI PMID PMC WoS
-
2016 | Journal Article
Monitoring of 30 marker candidates in early Parkinson disease as progression markers
Mollenhauer, B. ; Zimmermann, J.; Sixel-Döring, F.; Focke, N. K. ; Wicke, T.; Ebentheuer, J. & Schaumburg, M. et al. (2016)
Neurology, 87(2) pp. 168-177. DOI: https://doi.org/10.1212/WNL.0000000000002651
Details DOI PMID PMC WoS
-
2016 | Journal Article
Alzheimer's disease cerebrospinal fluid biomarkers predict cognitive decline in lewy body dementia
Abdelnour, C.; van Steenoven, I.; Londos, E.; Blanc, F.; Auestad, B.; Kramberger, M. G. & Zetterberg, H. et al. (2016)
Movement Disorders, 31(8) pp. 1203-1208. DOI: https://doi.org/10.1002/mds.26668
Details DOI PMID PMC WoS
-
2017 | Journal Article
A user's guide for α-synuclein biomarker studies in biological fluids: Perianalytical considerations
Mollenhauer, B. ; Batrla, R.; El-Agnaf, O.; Galasko, D. R; Lashuel, H.; Merchant, K. & Shaw, L. M et al. (2017)
Movement Disorders, 32(8) pp. 1117-1130. DOI: https://doi.org/10.1002/mds.27090
Details DOI PMID PMC
-
2018 | Journal Article
Biomarkers for Antidepressant Efficacy of Electroconvulsive Therapy: An Exploratory Cerebrospinal Fluid Study
Kranaster, L.; Hoyer, C.; Aksay, S.; Bumb, J.; Müller, N.; Zill, P. & Schwarz, M. et al. (2018)
Neuropsychobiology, 77(1) pp. 13-22. DOI: https://doi.org/10.1159/000491401
Details DOI
-
2018 | Journal Article
Cerebrospinal fluid and blood biomarkers for neurodegenerative dementias: An update of the Consensus of the Task Force on Biological Markers in Psychiatry of the World Federation of Societies of Biological Psychiatry
Lewczuk, P. ; Riederer, P.; O’Bryant, S. E.; Verbeek, M. M.; Dubois, B.; Visser, P. J. & Jellinger, K. A. et al. (2018)
The World Journal of Biological Psychiatry, 19(4) pp. 244-328. DOI: https://doi.org/10.1080/15622975.2017.1375556
Details DOI
-
2018 | Journal Article
Prevalence of the apolipoprotein E ε4 allele in amyloid β positive subjects across the spectrum of Alzheimer's disease
Mattsson, N.; Groot, C.; Jansen, W. J.; Landau, S. M.; Villemagne, V. L.; Engelborghs, S. & Mintun, M. M. et al. (2018)
Alzheimer's & Dementia, 14(7) pp. 913-924. DOI: https://doi.org/10.1016/j.jalz.2018.02.009
Details DOI
-
2018 | Journal Article |
The presubiculum is preserved from neurodegenerative changes in Alzheimer’s disease
Murray, C. E; Gami-Patel, P.; Gkanatsiou, E.; Brinkmalm, G.; Portelius, E.; Wirths, O. & Heywood, W. et al. (2018)
Acta Neuropathologica Communications, 6(1) art. 62. DOI: https://doi.org/10.1186/s40478-018-0563-8
Details DOI
-
2018 | Journal Article |
White paper by the Society for CSF Analysis and Clinical Neurochemistry: Overcoming barriers in biomarker development and clinical translation
Teunissen, C. E.; Otto, M. ; Engelborghs, S.; Herukka, S.-K.; Lehmann, S.; Lewczuk, P. & Lleó, A. et al. (2018)
Alzheimer's Research & Therapy, 10(1). DOI: https://doi.org/10.1186/s13195-018-0359-x
Details DOI
-
2018 | Journal Article
Association of Cerebral Amyloid-β Aggregation With Cognitive Functioning in Persons Without Dementia
Jansen, W. J.; Ossenkoppele, R.; Tijms, B. M.; Fagan, A. M.; Hansson, O.; Klunk, W. E. & van der Flier, W. M. et al. (2018)
JAMA Psychiatry, 75(1) pp. 84. DOI: https://doi.org/10.1001/jamapsychiatry.2017.3391
Details DOI
-
2018 | Journal Article |
Interlaboratory validation of cerebrospinal fluid α-synuclein quantification in the diagnosis of sporadic Creutzfeldt-Jakob disease
Kruse, N.; Heslegrave, A.; Gupta, V.; Foiani, M.; Villar-Piqué, A.; Schmitz, M. & Lehmann, S. et al. (2018)
Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring, 10 pp. 461-470. DOI: https://doi.org/10.1016/j.dadm.2018.06.005
Details DOI PMID PMC